INAB Q1 2026 Earnings Narrowed Losses Exceed Expectations as Clinical Progress Continues HEI Q4 2025 Earnings EPS Beats Estimates Amid Mixed Market Signal IRON Q1 2026 Earnings Narrower Loss Beats Estimates as Disc Medicine Advances Clinical Pipeline MBLY Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Operational Performance LOAR Q1 2026 Earnings EPS Surges 1087 Above Estimates Stock Edges Lower ProKidney Corp PROK Q1 2026 Earnings Narrowed Loss and Steady Progress in Kidney Disease Therapy